How to Buy Pre-IPO Shares: A Practical Investor Guide

The access routes, eligibility checks, settlement questions and risks to review before a private-share transaction. This evergreen guide is designed to stay useful between event-led news cycles.

Start with access, not the company name

Buying pre-IPO shares is not one standardized transaction. Access may come through a secondary marketplace, a broker, an employee-liquidity program, a fund, an SPV, or a regulated crowdfunding route. The route determines eligibility, minimum commitment, fees, settlement, information rights, and what you legally receive. For the foundation, read our pre-IPO investing guide.

First confirm that the provider can serve your jurisdiction and investor classification. A company being well known does not make its shares available to every investor. If a provider cannot explain its eligibility gate, source of shares, and regulatory basis in writing, stop before sharing money or identity documents. For the next comparison, see company directory.

Understand the instrument

You may be offered common shares, preferred shares, an interest in an SPV, a fund unit, a warrant, or a contractual right that is not the same as owning the company’s stock. Those instruments can have different liquidation preferences, voting rights, conversion terms, transfer restrictions, and tax treatment. For practical follow-through, review funds directory.

Request the legal name of the issuer, the exact security or vehicle, the share class, the number of shares or units, and the documents that govern the purchase. A headline such as “exposure to Company X” is not enough to establish what you own.

Check the price and the cap table context

A private share price is negotiated in a thin market. Compare it with the date and share class of the latest primary financing, but do not treat a financing valuation as a live quote. Preferred shares may have protections that common shares do not, and a secondary seller may accept a discount for speed, restrictions, or a need for liquidity.

Ask what dilution could follow, whether there are liquidation preferences senior to your security, and whether the company or existing investors have a right of first refusal. The price you pay should be analyzed together with the rights attached to the instrument and the cost of getting out.

Review the provider and the seller

The provider is part of the investment risk. Verify its legal entity, regulatory status where relevant, custody arrangement, fee schedule, complaints process, and track record of completing transfers. In a secondary transaction, ask whether the seller is an employee, an early investor, a fund, or an intermediary and why the shares are being sold.

Do not rely on screenshots, urgency, or an unverifiable allocation letter. Confirm payment instructions through a trusted channel, and make sure the documents identify the same parties as the account and transfer records. A credible process should give you time to read before money is due.

Execution and settlement

The execution sequence usually includes eligibility checks, an indication of interest, a final allocation, document signing, payment, issuer approval, and settlement into a custody or nominee account. Any of those steps can fail. Ask what happens to your funds if the issuer rejects the transfer or the allocation is reduced.

Confirm the settlement date, currency, bank fees, transfer taxes, custodian, statement format, and how fractional interests are handled. Keep copies of the signed documents, payment confirmation, cap-table or custody evidence, and every fee invoice.

What happens after you buy

Owning a private position often means waiting. There may be no regular price, no quarterly company reporting, and no reliable buyer. Track the company’s financing, regulatory filings, tender offers, transfer windows, and any lock-up or company-consent requirement, but treat each event as information rather than a promise of liquidity.

Before you buy, define the maximum amount you can lose, the minimum holding period you can tolerate, and the evidence that would make you add, hold, or decline. Pre-IPO investing is a process decision first and a company prediction second.